DOYLE MITTIE (Chief Medical Officer) sold 1.9% of their position (1K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $20.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2026ACC: 0001918845-26-000029
Officer· Chief Medical Officer
Since Feb 2026
-1K
Net shares
Net seller
$20.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1K acquired · 2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
$12.65
Trade value
$12.65K
% of position
1.9%
8/17/2026
51.78K→52.78K
Common Stock
Direct
Shares
−1K
Price / share
$20.00
Trade value
$20K
% of position
1.9%
8/17/2026
52.78K→51.78K
Total
Net shares
+0.00
Net value
-$7.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +1K | $12.65 | $12.65K | 1.9% | 51.78K | 52.78K |
| Common Stock Direct | 8/17/2026 | S · Sale | −1K | $20.00 | $20K | 1.9% | 52.78K | 51.78K |
| Total | +0.00 | -$7.35K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1K shares
Shares
−1K
Strike price
12.65
Held after
123.75K
Exercisable
—
8/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1K shares | 8/17/2026 | M · Option Exercise | −1K | 12.65 | — | 123.75K |